Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Farmers Insurance
Cerilliant
McKesson
Boehringer Ingelheim
Medtronic
Baxter
Express Scripts
Deloitte

Generated: June 18, 2018

DrugPatentWatch Database Preview

Trientine hydrochloride - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for trientine hydrochloride and what is the scope of trientine hydrochloride patent protection?

Trientine hydrochloride
is the generic ingredient in two branded drugs marketed by Aton and Watson Labs Teva, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for trientine hydrochloride. Three suppliers are listed for this compound.
Pharmacology for trientine hydrochloride
Drug ClassMetal Chelator
Mechanism of ActionMetal Chelating Activity
Medical Subject Heading (MeSH) Categories for trientine hydrochloride
Synonyms for trientine hydrochloride
1,2-Ethanediamine, N,N'-bis(2-aminoethyl)-, dihydrochloride
1,2-Ethanediamine,N1,N2-bis(2-aminoethyl)-, hydrochloride (1:2)
2,2'-Ethylenediiminobis(ethylamine) dihydrochloride
260T014
38260-01-4
AC1L2G5T
AC1Q3AVT
ACMC-1AD6N
AKOS028109579
API0004500
C-49679
C6H20Cl2N4
CCG-213505
CHEBI:9706
CTK8C5369
Cuprid
D00736
D09VOK
DB-049259
DTXSID2057863
EINECS 253-854-3
FT-0639448
HC3NX54582
Laszarin
LS-65337
Metalite
MK 0681
MK-0681
MK-681
N,N'-Bis(2-aminoethyl)-1,2-ethanediamine dihydrochloride
n,n'-bis(2-aminoethyl)ethan-1,2-diamindihydrochlorid
N,N'-bis(2-aminoethyl)ethane-1,2-diamine dihydrochloride
N,N'-Bis(2-aminoethyl)ethylenediamine dihydrochloride
N'-[2-(2-aminoethylamino)ethyl]ethane-1,2-diamine dihydrochloride
OR053760
PubChem21105
SCHEMBL506189
Syprine
Syprine (TN)
TC-164812
TJA-250
Trien dihydrochloride
Trientine Dihydrochloride
Trientine hydrochloride (JP17/USP)
Trientine hydrochloride [USAN]
Trientine Hydrochloride, Pharmaceutical secondary standard; traceable to USP
Trientine hydrochloride, United States Pharmacopeia (USP) Reference Standard
Triethylene tetramine dihydrochloride
Triethylenetetramine 2HCl
Triethylenetetramine dihydrochloride
Triethylenetetramine dihydrochloride, puriss., 2xcryst., >=99.0% (AT)
UNII-HC3NX54582
WYHIICXRPHEJKI-UHFFFAOYSA-N

US Patents and Regulatory Information for trientine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aton SYPRINE trientine hydrochloride CAPSULE;ORAL 019194-001 Nov 8, 1985 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Watson Labs Teva TRIENTINE HYDROCHLORIDE trientine hydrochloride CAPSULE;ORAL 207567-001 Feb 7, 2018 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Daiichi Sankyo
Farmers Insurance
Federal Trade Commission
McKinsey
Accenture
Mallinckrodt
Chubb
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.